NDC 17856-0179-2 - ACETAMINOPHEN
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-0179
- Requested NDC
- 17856-0179-2
- Package NDCs from labels
- 17856-0179-2, 17856-0179-1, 17856-0179-3, 17856-0179-5, 17856-0179-4, 17856-0179-6, 17856-0179-8, 17856-0179-7, 17856-0179-9
- Manufacturer
- ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS
- Effective date
- 2022-10-25
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ACETAMINOPHEN - ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS | ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS | 2022-10-25 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 17856-0179-3 | 2024-01-30 | C162847 | 48780-1 | 1030e364-fae1-111a-e063-dadaa90a10e2 | Acetaminophen Elxir Bubble Gum Flavor |
| 17856-0179-6 | 2024-01-30 | C162847 | 48780-1 | 1030e364-fae1-111a-e063-dadaa90a10e2 | Acetaminophen Elxir Bubble Gum Flavor |
| 17856-0179-9 | 2024-01-30 | C162847 | 48780-1 | 1030e364-fae1-111a-e063-dadaa90a10e2 | Acetaminophen Elxir Bubble Gum Flavor |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0179-1 | ACETAMINOPHEN | 48 in 1 BOX, UNIT-DOSE | ELIXIR | 48 | 1 | |
| 17856-0179-2 | ACETAMINOPHEN | 5 mL in 1 SYRINGE | ELIXIR | 5 | 1 | |
| 17856-0179-3 | ACETAMINOPHEN | 5 in 1 SYRINGE | ELIXIR | 5 | 1 | |
| 17856-0179-4 | ACETAMINOPHEN | 48 in 1 BOX, UNIT-DOSE | ELIXIR | 48 | 1 | |
| 17856-0179-5 | ACETAMINOPHEN | 7.5 mL in 1 SYRINGE | ELIXIR | 7.5 | 1 | |
| 17856-0179-6 | ACETAMINOPHEN | 5 in 1 SYRINGE | ELIXIR | 5 | 1 | |
| 17856-0179-7 | ACETAMINOPHEN | 120 in 1 BOX, UNIT-DOSE | ELIXIR | 120 | 1 | |
| 17856-0179-8 | ACETAMINOPHEN | 1.25 mL in 1 SYRINGE | ELIXIR | 1.25 | 1 | |
| 17856-0179-9 | ACETAMINOPHEN | 5 in 1 SYRINGE | ELIXIR | 5 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-0179 | ACETAMINOPHEN ELIXIR [ATLANTIC BIOLOGICALS CORP.] | 1 | Legacy NDC, 9 package rows | 20221104_aa1c0232-c806-4674-9ac3-6cae7f7499b4.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 17856-0179-1 | ML - Milliliter | 17856-0179 | 016a4150-0fa1-44fc-811f-8e76dd7a094f | 1 | 2023-06-06 |
| 17856-0179-4 | ML - Milliliter | 17856-0179 | 59723d69-8069-4855-922c-64cbc76e8023 | 1 | 2023-06-06 |
| 17856-0179-7 | ML - Milliliter | 17856-0179 | 765521b9-9146-42e4-9a09-51baa575ce31 | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Optase | GLYCERIN | Scope Health Inc | 10c3e31d-779d-8ff6-e063-6294a90acd39 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 9e96976b-2990-79e0-e053-2995a90a0f29 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | d81c1a4f-87b0-ee8c-e053-2995a90af9e5 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | f452a2c4-c869-7bf5-e053-2995a90ac1a0 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Additive Formula 3 | DEXTROSE MONOHYDRATE, TRISODIUM CITRATE DIHYDRATE, SODIUM CHLORIDE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, CITRIC ACID MONOHYDRATE, AND ADENINE | Terumo BCT, Ltd | 9a5247a1-cc05-442d-b2d0-950f887f03c2 | 2026-01-30 | Warnings, Adverse reactions | 2968PHW8QP |
| Migraine Relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Family Dollar (FAMILY WELLNESS) | bfcffa70-94a9-43de-9f22-4ed6a71c0a8d | 2026-01-29 | Warnings | 362O9ITL9D |
| Regener-Eyes Ophthalmic Solution LITE XL | GLYCERIN OPHTHALMIC SOLUTION | M & M PRODUCTS, L.L.C. | 47ab9609-4291-30b2-e063-6394a90a421e | 2026-01-29 | Warnings | PDC6A3C0OX |
| Regener-Eyes Ophthalmic Solution PROFESSIONAL STRENGTH XL | GLYCERIN OPHTHALMIC SOLUTION | M & M PRODUCTS, L.L.C. | 48d6dc98-66e8-b499-e063-6394a90ae935 | 2026-01-29 | Warnings | PDC6A3C0OX |
| EXTRA STRENGTH PAIN RELEIF | ACETAMINOPHEN | Strategic Sourcing Services, LLC | 0392db17-c4f3-424b-9dee-549fc5df61c5 | 2026-01-29 | Warnings | 362O9ITL9D |
| Regular Strength Pain Reliever | ACETAMINOPHEN | Strategic Sourcing Services, LLC | 959db1b0-2d9f-4857-b475-0fa027365212 | 2026-01-29 | Warnings | 362O9ITL9D |
| Optase | GLYCERIN | Scope Health Inc | 86c14327-ffc7-806e-e053-2991aa0aaf92 | 2026-01-29 | Warnings | PDC6A3C0OX |
| Night Time Cold and Flu ReadyInCase | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE | P & L Development, LLC | e7dd763b-3005-4723-933b-171eb772afee | 2026-01-29 | Warnings | 362O9ITL9D |
| Acetaminophen Extra Strength | ACETAMINOPHEN | FOODHOLD U.S.A., LLC | bc19bd47-69ea-4bcc-8d28-c043c9d32513 | 2026-01-29 | Warnings | 362O9ITL9D |
| Acetaminophen, Guaifenesin, Phenylephrine Hcl and Dextromethorphan HBr | ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HCL AND DEXTROMETHORPHAN HBR | Softgel Healthcare Pvt Ltd | 24bc9ae6-8e8f-c0a0-e063-6394a90a407f | 2026-01-28 | Warnings | 362O9ITL9D |
| Acetaminophen, Dextromethorphan Hydrobromide and Doxylamine Succinate | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE AND DOXYLAMINE SUCCINATE | Softgel Healthcare Private Limited | 229d1939-84a9-f18e-e063-6394a90aba30 | 2026-01-28 | Warnings | 362O9ITL9D |
| Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate and Phenylephrine Hydrochloride | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE AND PHENYLEPHRINE HYDROCHLORIDE | SOFTGEL HEALTHCARE PRIVATE LIMITED | 1fcbafaa-c871-db6d-e063-6394a90aab5e | 2026-01-28 | Warnings | 362O9ITL9D |
| Acetaminophen, Dextromethorphan Hydrobromide and Phenylephrine Hydrochloride | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE AND PHENYLEPHRINE HYDROCHLORIDE | SOFTGEL HEALTHCARE PRIVATE LIMITED | 1f7a6375-ab66-9782-e063-6394a90a99f3 | 2026-01-28 | Warnings | 362O9ITL9D |
| ONESSIP ADULT NIGHTTIME SEVERE COLD AND FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCI | MEDWISE LIFESCIENCES INC. | 4970b8bc-3c7b-4b8a-e063-6294a90a7f1b | 2026-01-28 | Warnings | 362O9ITL9D |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID MONOHYDRATE | Atlantic Biologicals Corp. | 42d837ae-2578-46df-92d2-24774964aaad | 2026-01-28 | Adverse reactions | 1Q73Q2JULR |
| Extra Strength Mini Softgels Pain Reliever | ACETAMINOPHEN | THE KROGER CO | b49aae4f-b040-44a0-be73-cdf45cf14d7e | 2026-01-28 | Warnings | 362O9ITL9D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.